Atossa preclinical study on endoxifen compounds published in npj

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. BE
3. PANW
4. CL
5. SNDK
6. TAP
7. DELL
8. ROIV
9. ANET
10. NKE

Go back to Atossa preclinical study on endoxifen compounds published in npj
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.52 --0 (-0%)
Previous Close $2.52    52 Week High $3.64 
Open $2.52    52 Week Low $0.14 
Day High $2.52    P/E N/A 
Day Low $2.52    EPS $0.00 
Volume 8